MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC), with potential to treat tumor-induced bone disease (TIBD).

Tetramethylthiuram monosulfide is widely used as a catalyst in rubber-processing techniques, it possesses a medium-degree toxicity and causes point mutations in strains TA 100 and TA 1535 (Salmonella typhimurium LT 2).

Antitumor agent-19 is an antitumor agent targeting tumor-associated macrophages (TAMs) to serve as an effective TAMs modulator (EC50s: 17.18 μM and 18.87 μM in the RAW 264.7 cells and the BMDM cells).